← All organizations

Arrow Therapeutics

For profit

Also known as: ARROW INTL

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

First marketed drug

Last known activity

Dec 1, 2010

Acquired by AstraZeneca on Jan 1, 2007

Timeline

1990s

Jan 1, 1998
Arrow Therapeutics— Founded

2000s

Jan 1, 2007
AstraZeneca— Acquired By

2020s

May 21, 2021
lenalidomide— Marketing Organization

Drugs by trial phase (3 distinct, 6 trials)

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

azd4316

Indications

Studied for

Marketed drugs (1)

lenalidomide

Recent trials (6)

NCT01247103Study directorPhase 1Dec 1, 2010
NCT01097408Lead sponsorPhase 1Mar 1, 2010
NCT00906256Lead sponsorPhase 1Apr 1, 2009
NCT00781976Lead sponsorPhase 1Nov 1, 2008
NCT00522808Lead sponsorPhase 1/Phase 2Aug 1, 2007
NCT00232635Lead sponsorPhase 2Sep 1, 2005

Details

Founded: London, GB Jan 1, 1998
Last known activity: Dec 1, 2010